Title: Phase II, Open-Label, Randomized, Multicenter Study Comparing the Efficacy and Safety or Olaparib, a Poly (ADP-Ribose) Polymerase Inhibitor, and Pegylated Liposomal Doxorubicin in Patients With BRCA1 or BRCA2 Mutations and Recurrent Ovarian Cancer
Authors: Kaye, Stan ×
Lubinski, Jan
Matulonis, Ursula
Ern Ang, Joo
Gourley, Charlie
Karlan, Beth
Amnon, Amit
Bell-McGuinn, Katherine
Chen, Lee-May
Friedlander, Michael
Safra, Tamar
Vergote, Ignace
Wickens, Mark
Lowe, Elizabeth
Carmichael, James
Kaufman, Bella #
Issue Date: 27-Dec-2012
Publisher: Grune & Stratton
Series Title: Journal of Clinical Oncology vol:30 issue:4 pages:372-9
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science